White-Coat, Masked HTN Tied to Target Organ Complications

Share this content:
White-Coat, Masked HTN Tied to Target Organ Complications
White-Coat, Masked HTN Tied to Target Organ Complications

MONDAY, Nov. 16, 2015 (HealthDay News) -- Both white-coat hypertension (WCH) and masked hypertension (MH) are associated with target organ complications and cardiovascular event risk, according to a study published in the Nov. 17 issue of the Journal of the American College of Cardiology.

Danielle Tientcheu, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues determined hypertensive target organ damage and adverse cardiovascular outcomes associated with WCH (high clinic BP, normal home BP), MH (high home BP, normal clinic BP), and sustained hypertension in a large multiethnic population cohort of 3,027 subjects. Over a median follow-up period of nine years, correlations for WCH and MH with incident cardiovascular outcomes (coronary heart disease, stroke, atrial fibrillation, heart failure, and cardiovascular death) were assessed.

The researchers found that the sample-weighted prevalence rates were 3.3 percent for WCH and 17.8 percent for MH. Independent correlations were seen for both WCH and MH with increased aortic pulsed wave velocity, cystatin C, and urinary albumin-to-creatinine ratio. Compared with the normotensive group, both WCH and MH correlated with increased cardiovascular events (adjusted hazard ratios, 2.09 and 2.03, respectively) after adjustment for traditional cardiovascular risk factors.

"Because MH is common and associated with an adverse cardiovascular profile, home BP monitoring should be routinely performed among U.S. adults," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Generic EpiPen

FDA Approves First Generic EpiPen

Approval will address both rising costs and shortages of epinephrine

Report Details Corneal Infection Tied to Sleeping in Contacts

Report Details Corneal Infection Tied to Sleeping in ...

Six patients reported sleeping in lenses on regular basis; most had vision loss, permanent damage

Honey May Protect Children Who Swallow Button Batteries

Honey May Protect Children Who Swallow Button Batteries

Honey and Carafate appear to rapidly protect against batteries' caustic effects

is free, fast, and customized just for you!




Already a member?

Sign In Now »